Mail

LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

Insider Transactions

Insider Transactions

Currency in USD

Insider Purchases Last 6 Months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net Shares Purchased (Sold)	0	0
Total Insider Shares Held	15.74M	N/A
% Net Shares Purchased (Sold)	0.00%	N/A

Net Institutional Purchases Prior Quarter to Latest Quarter	Shares
Net Shares Purchased (Sold)	N/A
% Change in Institutional Shares Held	N/A

Insider Transactions Reported - Last Two Years

Insider	Transaction	Type	Value	Date	Shares
SPISSINGER ALLAN HORST Chief Financial Officer	Conversion of Exercise of derivative security at price 0.37 per share.	Direct	18,500	Feb. 15, 2019	50,000
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Stock Award(Grant) at price 2.07 per share.	Direct	67,275	Aug. 31, 2018	32,500
DOCHERTY JOHN MARTIN President	Stock Award(Grant) at price 2.07 per share.	Indirect	75,555	Aug. 31, 2018	36,500
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Stock Gift at price 0.00 per share.	Direct	0	Aug. 14, 2018	500,000
BUNKA CHRISTOPHER ANDREW Officer, Director and Beneficial Owner	Stock Award(Grant) at price 1.78 per share.	Direct	144,625	Aug. 3, 2018	81,250
DOCHERTY JOHN MARTIN Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 1.78 per share.	Indirect	487,275	Aug. 3, 2018	273,750
BUNKA CHRISTOPHER ANDREW Chief Executive Officer	Conversion of Exercise of derivative security at price 0.09 - 0.14 per share.	Indirect	85,275	Jun. 18, 2018	697,500
MCKECHNIE WILLIAM EDWARD Director	Sale at price 1.52 per share.	Direct	76,000	May 31, 2018	50,000